{"id":52253,"date":"2025-10-16T12:31:19","date_gmt":"2025-10-16T07:01:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=52253"},"modified":"2025-10-16T12:32:28","modified_gmt":"2025-10-16T07:02:28","slug":"rubicon-research-ipo-listing","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/rubicon-research-ipo-listing\/","title":{"rendered":"Rubicon Research IPO Listing at 27.84% premium at \u20b9620 Per Share"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Latest Updates on Rubicon Research Limited<\/em><\/strong><\/a><\/p><p><strong><em>Rubicon Research IPO Listing:<\/em><\/strong> The Rubicon Research IPO was subscribed 109.35 times at the close. In this subscription, qualified institutional buyers (QIBs) received 102.70 times the allocation, and non-institutional investors (NIIs) received 102.70 times the allocation. The retail quota of the issue was subscribed to 9.99%. Before delving deeper into the topic, go through the details of the Rubicon Research IPO.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-ipo-listing\/#Rubicon_Research_IPO_Listing\" title=\"Rubicon Research IPO Listing\">Rubicon Research IPO Listing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-ipo-listing\/#Rubicon_Research_IPO_Details\" title=\"Rubicon Research IPO Details\">Rubicon Research IPO Details<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-ipo-listing\/#About_Rubicon_Research_Limited\" title=\"About Rubicon Research Limited\">About Rubicon Research Limited<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-ipo-listing\/#Rubicon_Research_Limited_Financials\" title=\"Rubicon Research Limited Financials\">Rubicon Research Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-ipo-listing\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/rubicon-research-ipo-listing\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Rubicon_Research_IPO_Listing\"><\/span><strong>Rubicon Research IPO Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the NSE, shares are listed at \u20b9620 per share, representing a 28.74% premium over the issue price of \u20b9485 per share. On the other hand, BSE platform shares are trading at \u20b9620.10, reflecting a 27.86% premium.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Rubicon_Research_IPO_Details\"><\/span><strong>Rubicon Research IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>It is a book-building IPO of \u20b91,377.50 crores, comprising an entirely fresh issue of \u20b91.03 crores.&nbsp; The problem will be listed on BSE and NSE on its tentative listing date, 16th October 2025. The Rubicon Research IPO date is scheduled for 9th October 2025 to 13th October 2025. The face value of Rubicon Research&#8217;s IPO shares is \u20b91 per share, and the IPO price is set between \u20b9461 and \u20b9485 per share.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>9th October 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>13th October 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>14th October 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>15th October 2025<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>37,00,000 shares(aggregating up to \u20b952.91 Cr)<\/td><\/tr><tr><td><strong>Fresh Issue<\/strong><\/td><td>1,03,09,762 share(aggregating up to \u20b9500.00 Cr)<\/td><\/tr><tr><td><strong>Offer for Sale<\/strong><\/td><td>1,80,92,762 shares of \u20b91(aggregating up to \u20b9877.50 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b91 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>30 shares<\/td><\/tr><tr><td><strong>Issue Price Final<\/strong><\/td><td>\u20b9461 and \u20b9485 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; NSE<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>16th October 2025<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Rubicon_Research_Limited\"><\/span><strong>About Rubicon Research Limited<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Rubicon Research Limited, established in 1999, is a pharmaceutical company engaged in the development, manufacturing, and commercialisation of differentiated formulations. As of June 30, 2025, Rubicon Research had a portfolio of 72 active Abbreviated New Drug Application (ANDA) and New Drug Application (NDA) products approved by the US FDA. The company\u2019s portfolio includes 66 commercialised products, with a US generic pharmaceutical market size of USD 2,455.7 million, of which Rubicon Research Limited contributed USD 195 million in Fiscal 2024. As of June 30, 2025, the company has 17 new products awaiting US FDA ANDA approval and 63 products at various stages of development. As of June 30, 2025, the company marketed over 350 SKUs to 96 customers, including three major wholesalers who account for more than 90% of wholesale drug distribution in the US. The company also supplies group purchasing organisations (GPOs), national pharmacy chains, regional pharmacy chains, and managed care organisations.&nbsp;&nbsp;&nbsp;&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Rubicon_Research_Limited_Financials\"><\/span><strong>Rubicon Research Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the <strong>Rubicon Research&nbsp; IPO. <\/strong>Refer to the table to learn about Rubicon Research Limited&#8217;s financial information.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>1,451.43<\/td><td>1,109.49<\/td><td>749.70<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>1,296.22<\/td><td>872.39<\/td><td>419.00<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>134.36<\/td><td>91.01<\/td><td>-16.89<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>540.98<\/td><td>385.00<\/td><td>286.38<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>267.89<\/td><td>173.09<\/td><td>43.97<\/td><\/tr><tr><td><strong>Reserve and Surplus<\/strong><\/td><td>525.57<\/td><td>369.79<\/td><td>281.31<\/td><\/tr><tr><td><strong>Total Borrowing<\/strong><\/td><td>393.17<\/td><td>396.41<\/td><td>317.91<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Rubicon Research Limited&#8217;s revenue increased by 49% from \u20b9872.39 crore in March 2024 to \u20b91,296.22 crore in March 2025. Moreover, the company&#8217;s PAT rose by 48% from \u20b991.01 crores to \u20b9134.36 crores.<\/p><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/top-10-penny-stocks-in-india\">Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/best-stocks-to-buy-today-6\">Best Stocks to Buy Today: Explore Best Stocks With Expected Trends<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/milky-mist-dairy-foods-ipo-details\">Milky Mist Dairy Foods IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/karbonsteel-engineering-ipo-gmp-review\">Karbonsteel Engineering IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/taurian-mps-ipo-gmp-review\">Taurian MPS IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/shringar-house-of-mangalsutra-ipo-gmp-review\">Shringar House of Mangalsutra IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/dev-accelerator-ipo-gmp-review\">Dev Accelerator IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/vigor-plast-india-ipo-listing-preview\">Vigor Plast India IPO Listing Preview: What to Expect Now?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/krupalu-metals-ipo-gmp-live-updates-2\">Krupalu Metals IPO GMP: Day 3 IPO Live Updates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Latest Updates on Rubicon Research Limited Rubicon Research IPO Listing: The Rubicon Research IPO was subscribed 109.35 times at the close. In this subscription, qualified institutional buyers (QIBs) received 102.70 times the allocation, and non-institutional investors (NIIs) received 102.70 times the allocation. The retail quota of the issue was<\/p>\n","protected":false},"author":23,"featured_media":52254,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[2744],"class_list":["post-52253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-rubicon-research-ipo"],"metadata":{"_edit_lock":["1760598149:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["79"],"rank_math_title":["Rubicon Research IPO Listing: Check Experts' Verdicts Here"],"rank_math_description":["Rubicon Research IPO Listing at \u20b9620, a premium of 27.84% over the IPO price of \u20b9485 per share. What should be your next move on the Rubicon Research IPO? Read more.\r\n\r\n"],"rank_math_focus_keyword":["Rubicon Research IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["52254"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["3998"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/rubicon-research-ipo-listing"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/10\/16122609\/Rubicon-Research-IPO-Listing-Today.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/52253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=52253"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/52253\/revisions"}],"predecessor-version":[{"id":52255,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/52253\/revisions\/52255"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/52254"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=52253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=52253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=52253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}